Hannah Shen Email & Phone Number

Kekulai is an AI drug discovery company focused on unlocking the largely untapped potential of the beyond rule-of-5 (bRo5) chemical space to develop life-changing medicine. We welcome partnership conversations to explore different ways to leverage the platform.Kekulai's Auraboros platform has three key features:* Ligand-based foundation model: inferencing billions of compounds to efficiently explore the bRo5 chemical space * Tight integration with make-on-demand synthesis: rapid and cost-effective testing of the novel compounds identified by the platform, creating a flywheel effect where the data generated is used to further improve the model's predictions*Designed for generalizability: generalizability is crucial for navigating the bRo5 chemical space due to its sparse data. Auraboros significantly outperforms existing competitors in predicting 3D E-Shape on test datasets

Work with biotech VCs and therapeutics companies (seed to series C) to advise on corporate strategy (governance structure, portfolio planning, and BD & fundraising strategy) ad oversee operations (partnership deals, in-licensing, out-licensing, finance, project leads). Some examples including:• Fractional COO for a musculoskeletal seed co: fundraising, corporate strategy, finance, HR• Fractional CBO for series c platform co: outlicensing, platform partnership, pipeline strategy • BD for platform series A co: inlicensing a cardiometabolic asset close to DC• Advisor for genAI platform NewCo: fundraising and corporate strategy• Strategy for platform seed co: pipeline strategy across rare and common CNS indications• Strategy for platform seed co: lead indication selection across liver diseases

AcaciaBio is a biotech company focused on advancing targeted therapies for women's and fetal health.

Menlo Park, California, Us

2023 Fall cohort of female founders and leaders

Emeryville, Ca, Us

As part of the executive team, I worked directly with the CEO and board to reformulate the long-range plan and R&D strategy. Main focus areas include runway extension, reframing company value proposition, pipeline strategy, scenario planning for the next round financing, and people development.

Palo Alto, California, Us

I grew and led BridgeBio’s Asset Acquisition team from series B to post-IPO.- Incubated 15 new drug programs in rare diseases and precision oncology; most advanced is now in Ph3 trial - Launched BridgeBioX, including developing the company strategy and its entire portfolio- Built and managed two high-performing, efficient teams driving BD and strategy

Palo Alto, California, Us

Palo Alto, California, Us

Palo Alto, California, Us

San Francisco, California, Us

Benchling is a cloud-based platform for biotech R&D. As the third business hire, I played a key role in developing the company's marketing and sales strategy. The results led to an 8x increase in revenue within the first 18 months and secured Benchling's first two deals with top 5 biopharma companies.

Doctor Of Philosophy - Phd, Systems Neuroscience/Molecular And Cellular Biology

Education record

Bachelor Of Science (Bs), Biochemistry